Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             250 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acid-related disorders in the elderly Franceschi, Marilisa
2009
50-51 6 p. 839-848
10 p.
artikel
2 Action and function of Akkermansia muciniphila in microbiome ecology, health and disease Ottman, Noora
2017
50-51 6 p. 637-642
artikel
3 Action and function of Chromobacterium violaceum in health and disease: Violacein as a promising metabolite to counteract gastroenterological diseases Justo, Giselle Zenker
2017
50-51 6 p. 649-656
artikel
4 Action and function of Faecalibacterium prausnitzii in health and disease Ferreira-Halder, Carmen Veríssima
2017
50-51 6 p. 643-648
artikel
5 Adaptation following intestinal resection: mechanisms and signals Thiesen Jr., A
2003
50-51 6 p. 981-995
15 p.
artikel
6 Advanced endoscopic imaging for gastric cancer assessment: New insights with new optics? Serrano, M.
2014
50-51 6 p. 1079-1091
13 p.
artikel
7 Ageing: definitions, mechanisms and the magnitude of the problem Balcombe, Nicholas R
2001
50-51 6 p. 835-849
15 p.
artikel
8 Aims & Scope/ Editorial Board 2009
50-51 6 p. iii-
1 p.
artikel
9 Aims & Scope/ Editorial Board 2014
50-51 6 p. iii-
1 p.
artikel
10 Aims & Scope/ Editorial Board 2015
50-51 6 p. iii-
1 p.
artikel
11 Aims & Scope/ Editorial Board 2011
50-51 6 p. iii-
1 p.
artikel
12 Aims & Scope/Editorial Board 2016
50-51 6 p. iii-
1 p.
artikel
13 Aims & Scope/ Editorial Board 2013
50-51 6 p. iii-
1 p.
artikel
14 Aims & Scope/ Editorial Board 2012
50-51 6 p. iii-
1 p.
artikel
15 Aims & scope/editorial board 2006
50-51 6 p. iii-
1 p.
artikel
16 Aims ; scope/editorial board 2004
50-51 6 p. iii-
1 p.
artikel
17 Aims & scope/Editorial board 2007
50-51 6 p. iii-
1 p.
artikel
18 Aims & Scope/ Editorial Board 2010
50-51 6 p. iii-
1 p.
artikel
19 Aims & scope/editorial board 2005
50-51 6 p. iii-
1 p.
artikel
20 Aims & scope/editorial board 2008
50-51 6 p. iii-
1 p.
artikel
21 Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket Boeckxstaens, Guy E.
2010
50-51 6 p. 821-829
9 p.
artikel
22 Amsterdam and Netherlands gastroenterology: a historical perspective Modlin, Irvin M.
2002
50-51 6 p. 971-998
28 p.
artikel
23 An algorithm for diagnosis and treatment of refractory GERD Hershcovici, Tiberiu
2010
50-51 6 p. 923-936
14 p.
artikel
24 A pragmatic symptom-based approach Kuo, Paul
2010
50-51 6 p. 765-773
9 p.
artikel
25 Assessing and interviewing the elderly: interpretation of signs and symptoms Sklar, Manuel
2001
50-51 6 p. 851-867
17 p.
artikel
26 Assessment of a cancer screening program Rabeneck, Linda
2015
50-51 6 p. 979-985
7 p.
artikel
27 Atrophy–metaplasia–dysplasia–carcinoma sequence in the stomach: a reality or merely an hypothesis? Meining, A.
2001
50-51 6 p. 983-998
16 p.
artikel
28 Autoimmune hepatitis in special patient populations Czaja, Albert J.
2011
50-51 6 p. 689-700
12 p.
artikel
29 Autoimmune liver disease Manns, Michael P.
2011
50-51 6 p. 641-642
2 p.
artikel
30 Autoimmune liver diseases in children – What is different from adulthood? Mieli-Vergani, Giorgina
2011
50-51 6 p. 783-795
13 p.
artikel
31 Biliary tract cancers: From pathogenesis to endoscopic treatment Demols, Anne
2007
50-51 6 p. 1015-1029
15 p.
artikel
32 Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) Kanakis, George
2012
50-51 6 p. 791-802
12 p.
artikel
33 Biotherapies for GEP-NETs Öberg, Kjell
2012
50-51 6 p. 833-841
9 p.
artikel
34 Cancer surveillance in gastroenterology practice Kaminski, Michal F.
2016
50-51 6 p. 853-854
2 p.
artikel
35 Care of the elderly with gastrointestinal problems in family practice Newton, Julia L.
2001
50-51 6 p. 1013-1025
13 p.
artikel
36 Changing epidemiology of hepatocellular carcinoma in Asia Goh, George Boon-Bee
2015
50-51 6 p. 919-928
10 p.
artikel
37 Chemoprevention trials of GI cancers in Asia Li, James Weiquan
2015
50-51 6 p. 967-978
12 p.
artikel
38 Chronic gastritis – An update Varbanova, Mariya
2014
50-51 6 p. 1031-1042
12 p.
artikel
39 Chronic viral hepatitis as a public health issue in the world Lavanchy, Daniel
2008
50-51 6 p. 991-1008
18 p.
artikel
40 Classification, epidemiology and aetiology Koffeman, Geert I
2003
50-51 6 p. 879-893
15 p.
artikel
41 Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma Ferreira, Rui M.
2014
50-51 6 p. 1003-1015
13 p.
artikel
42 Colon cancer and the elderly: From screening to treatment in management of GI disease in the elderly Holt, Peter R.
2009
50-51 6 p. 889-907
19 p.
artikel
43 Colonic and rectal NET's Mandair, Dalvinder
2012
50-51 6 p. 775-789
15 p.
artikel
44 Colorectal cancer screening Winawer, Sidney J.
2007
50-51 6 p. 1031-1048
18 p.
artikel
45 Complications of bile-duct stones: acute cholangitis and pancreatitis van Erpecum, Karel J.
2006
50-51 6 p. 1139-1152
14 p.
artikel
46 Constipation in old age Gallagher, Paul
2009
50-51 6 p. 875-887
13 p.
artikel
47 Corrigendum to “Current challenges in liver transplantation for hepatocellular carcinoma” [Best Pract Res Clin Gastroenterol 28 (2014) 867–879] Bhoori, Sherrie
2014
50-51 6 p. 1115-1116
2 p.
artikel
48 Cost-effectiveness of Barrett's oesophagus screening and surveillance Gordon, Louisa G.
2013
50-51 6 p. 893-903
11 p.
artikel
49 Cost-effectiveness of biological agents used in ulcerative colitis Lee, Jeannie K.
2013
50-51 6 p. 949-960
12 p.
artikel
50 Cost-effectiveness of liver cancer screening Cucchetti, Alessandro
2013
50-51 6 p. 961-972
12 p.
artikel
51 Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention Lansdorp-Vogelaar, Iris
2013
50-51 6 p. 933-947
15 p.
artikel
52 Cost effectiveness of surveillance for GI cancers Omidvari, Amir-Houshang
2016
50-51 6 p. 879-891
13 p.
artikel
53 Cost-effectiveness of viral hepatitis B & C treatment Toy, Mehlika
2013
50-51 6 p. 973-985
13 p.
artikel
54 Current trends in the treatment of upper gastrointestinal disease Sachs, George
2002
50-51 6 p. 835-849
15 p.
artikel
55 Demography of aging and the epidemiology of gastrointestinal disorders in the elderly Goldacre, Michael J.
2009
50-51 6 p. 793-804
12 p.
artikel
56 Diagnosing portal hypertension Wongcharatrawee, Suchat
2000
50-51 6 p. 881-894
14 p.
artikel
57 Diagnosis and initial management of Gastroesophageal complications Kamal, Afrin
2010
50-51 6 p. 799-820
22 p.
artikel
58 Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes Chevaliez, Stéphane
2008
50-51 6 p. 1031-1048
18 p.
artikel
59 Diagnosis and treatment of hepatic encephalopathy Blei, Andres T
2000
50-51 6 p. 959-974
16 p.
artikel
60 Diagnosis and treatment of hepatorenal syndrome Ginès, Pere
2000
50-51 6 p. 945-957
13 p.
artikel
61 Diagnosis of primary biliary cirrhosis Hirschfield, Gideon M.
2011
50-51 6 p. 701-712
12 p.
artikel
62 Diagnosis, treatment and prevention of spontaneous bacterial peritonitis Fernández, Javier
2000
50-51 6 p. 975-990
16 p.
artikel
63 Diagnostic criteria for autoimmune hepatitis Lohse, Ansgar W.
2011
50-51 6 p. 665-671
7 p.
artikel
64 Diet, microbiome, and colorectal cancer Konstantinov, Sergey R.
2017
50-51 6 p. 675-681
artikel
65 Disease definition, clinical manifestations, epidemiology and natural history of GERD Vakil, Nimish
2010
50-51 6 p. 759-764
6 p.
artikel
66 Drug metabolism and drug interactions in the elderly Herrlinger, Charlotte
2001
50-51 6 p. 897-918
22 p.
artikel
67 Drug-related damage of the ageing gastrointestinal tract Sostres, Carlos
2009
50-51 6 p. 849-860
12 p.
artikel
68 Early diagnosis and treatment of hepatocellular carcinoma Llovet, Josep M
2000
50-51 6 p. 991-1008
18 p.
artikel
69 Early esophageal cancer screening in China Gao, Qin-Yan
2015
50-51 6 p. 885-893
9 p.
artikel
70 Economic evaluation of colorectal cancer (CRC) screening Cruzado, José
2013
50-51 6 p. 867-880
14 p.
artikel
71 Editorial Board 2003
50-51 6 p. iii-
1 p.
artikel
72 Effective screening for early diagnosis of pancreatic cancer Hanada, Keiji
2015
50-51 6 p. 929-939
11 p.
artikel
73 Endoscopic detection of early lower gastrointestinal cancer Kiesslich, R.
2005
50-51 6 p. 941-961
21 p.
artikel
74 Endoscopic detection of early upper GI cancers Wong Kee Song, Louis-Michel
2005
50-51 6 p. 833-856
24 p.
artikel
75 Endoscopic mucosal resection for early-stage gastrointestinal cancers Inoue, Haruhiro
2005
50-51 6 p. 871-887
17 p.
artikel
76 Endoscopic therapy of early gastric cancer Yamamoto, Hironori
2005
50-51 6 p. 909-926
18 p.
artikel
77 Endoscopic therapy of lower gastrointestinal cancer Rembacken, B.J.
2005
50-51 6 p. 979-992
14 p.
artikel
78 Endoscopic treatment of high-grade intraepithelial neoplasia and early cancer in Barrett oesophagus Bergman, Jacques J.G.H.M.
2005
50-51 6 p. 889-907
19 p.
artikel
79 Endoscopy in gastro-oesophageal reflux disease Hatlebakk, Jan G.
2010
50-51 6 p. 775-786
12 p.
artikel
80 Endoscopy in the elderly patient de la Mora, Guillermo
2001
50-51 6 p. 999-1012
14 p.
artikel
81 Ensocopic-endoluminal therapies. A critical appraisal Louis, Hubert
2010
50-51 6 p. 969-979
11 p.
artikel
82 Enteral and parenteral nutrition in the care of patients with short-bowel syndrome Vanderhoof, Jon A
2003
50-51 6 p. 997-1015
19 p.
artikel
83 Environmental – Lifestyle related factors Roman, Sabine
2010
50-51 6 p. 847-859
13 p.
artikel
84 Epidemiology of gallbladder stone disease Shaffer, Eldon A.
2006
50-51 6 p. 981-996
16 p.
artikel
85 Epidemiology of gastroenteropancreatic neuroendocrine tumours Fraenkel, M.
2012
50-51 6 p. 691-703
13 p.
artikel
86 Epidemiology of oesophagogastric cancer Lambert, R.
2007
50-51 6 p. 921-945
25 p.
artikel
87 Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic) Tazuma, Susumu
2006
50-51 6 p. 1075-1083
9 p.
artikel
88 Erratum 2000
50-51 6 p. 1075-
1 p.
artikel
89 Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments Hunt, Richard H.
2002
50-51 6 p. 869-883
15 p.
artikel
90 Expected developments in hepatology Forns, Xavier
2002
50-51 6 p. 957-970
14 p.
artikel
91 Experimental approaches: dietary and hormone therapy Jeppesen, P.B
2003
50-51 6 p. 1041-1054
14 p.
artikel
92 Facts and fantasies in extra-oesophageal symptoms in GORD Labenz, J.
2010
50-51 6 p. 893-904
12 p.
artikel
93 Functional disorders of the gastrointestinal tract: Cost effectiveness review Mapel, Douglas W.
2013
50-51 6 p. 913-931
19 p.
artikel
94 Future developments in endoscopic imaging Fockens, Paul
2002
50-51 6 p. 999-1012
14 p.
artikel
95 Future treatment options for HCV: Double, triple, what is the optimal combination? Kronenberger, Bernd
2008
50-51 6 p. 1123-1136
14 p.
artikel
96 Gallstone disease: primary and secondary prevention Venneman, Niels G.
2006
50-51 6 p. 1063-1073
11 p.
artikel
97 Gastric acid secretion: Changes during a century Di Mario, Francesco
2014
50-51 6 p. 953-965
13 p.
artikel
98 Gastric and duodenal neuroendocrine tumours O'Toole, Dermot
2012
50-51 6 p. 719-735
17 p.
artikel
99 Gastric MALT lymphoma – Update on diagnosis and treatment Fischbach, Wolfgang
2014
50-51 6 p. 1069-1077
9 p.
artikel
100 Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) de Herder, Wouter W.
2012
50-51 6 p. 689-690
2 p.
artikel
101 Gastrointestinal bleeding in the elderly Lingenfelser, Thomas
2001
50-51 6 p. 963-982
20 p.
artikel
102 Gastrointestinal endoscopy in the elderly: Current issues Mönkemüller, Klaus
2009
50-51 6 p. 821-827
7 p.
artikel
103 Gastro-oesophageal reflux disease Sifrim, Daniel
2010
50-51 6 p. 757-758
2 p.
artikel
104 Generalizability of cost–utility analyses across countries and settings Ginsberg, Gary M.
2013
50-51 6 p. 845-852
8 p.
artikel
105 Genetics in primary sclerosing cholangitis Folseraas, Trine
2011
50-51 6 p. 713-726
14 p.
artikel
106 Helicobacter pylori: The balance between a role as colonizer and pathogen Otero, Laura Llorca
2014
50-51 6 p. 1017-1029
13 p.
artikel
107 Hepatitis B vaccination and prevention of hepatocellular carcinoma Kao, Jia-Horng
2015
50-51 6 p. 907-917
11 p.
artikel
108 Hepatobiliary, renal and bone complications of intestinal failure Nightingale, Jeremy Mark Darby
2003
50-51 6 p. 907-929
23 p.
artikel
109 Hepatocellular carcinoma in viral hepatitis: Improving standard therapy Masuzaki, Ryota
2008
50-51 6 p. 1137-1151
15 p.
artikel
110 Hereditary diffuse gastric cancer – Pathophysiology and clinical management Pinheiro, Hugo
2014
50-51 6 p. 1055-1068
14 p.
artikel
111 Immunology of hepatitis B and hepatitis C virus infections Boonstra, Andre
2008
50-51 6 p. 1049-1061
13 p.
artikel
112 Implementation of gastric cancer screening – The global experience Leja, Mārcis
2014
50-51 6 p. 1093-1106
14 p.
artikel
113 Index 2000
50-51 6 p. I1-I8
nvt p.
artikel
114 Index 2001
50-51 6 p. I1-I3
nvt p.
artikel
115 Indications for specific therapy in the rehabilitation of patients with the short-bowel syndrome Wilmore, Douglas W
2003
50-51 6 p. 895-906
12 p.
artikel
116 Individual risk stratification of gastric cancer: Evolving concepts and their impact on clinical practice Rugge, Massimo
2014
50-51 6 p. 1043-1053
11 p.
artikel
117 Intervening in disease through genetically-modified bacteria Ferreira, Adilson K.
2017
50-51 6 p. 693-697
artikel
118 Intervention in gastro-enteropancreatic neuroendocrine tumours Baudin, Eric
2012
50-51 6 p. 855-865
11 p.
artikel
119 Intestinal absorption in health and disease: micronutrients Basu, Tapan K
2003
50-51 6 p. 957-979
23 p.
artikel
120 Intestinal absorption in health and disease—sugars Wright, Ernest M.
2003
50-51 6 p. 943-956
14 p.
artikel
121 Intestinal epithelial pathobiology: past, present and future Gewirtz, Andrew T.
2002
50-51 6 p. 851-867
17 p.
artikel
122 Intestinal microbiome and permeability in patients with autoimmune hepatitis Cai, Wangfeng
2017
50-51 6 p. 669-673
artikel
123 Introduction to health economics and decision-making: Is economics relevant for the frontline clinician? Goeree, Ron
2013
50-51 6 p. 831-844
14 p.
artikel
124 Is stomach spontaneously ageing? Pathophysiology of the ageing stomach Salles, Nathalie
2009
50-51 6 p. 805-819
15 p.
artikel
125 Is there an optimal macronutrient mix for weight loss and weight maintenance? Wilkinson, Dana Lee
2004
50-51 6 p. 1031-1047
17 p.
artikel
126 Laboratory based investigations for diagnosing gastroesophageal reflux disease Dolder, Mathias
2010
50-51 6 p. 787-798
12 p.
artikel
127 Lifestyle alters GUT-bacteria function: Linking immune response and host Jazayeri, Omid
2017
50-51 6 p. 625-635
artikel
128 Liver disorders in the elderly Floreani, Annarosa
2009
50-51 6 p. 909-917
9 p.
artikel
129 Liver transplantation in autoimmune liver diseases Ilyas, Jawad A.
2011
50-51 6 p. 765-782
18 p.
artikel
130 Liver transplantation in viral hepatitis: Prevention of recurrence Roche, Bruno
2008
50-51 6 p. 1153-1169
17 p.
artikel
131 Liver transplantation of patients in end-stage cirrhosis Haydon, Geoffrey H.
2000
50-51 6 p. 1049-1073
25 p.
artikel
132 Management of common bile-duct stones and associated gallbladder stones: surgical aspects Boerma, Djamila
2006
50-51 6 p. 1103-1116
14 p.
artikel
133 Management of intrahepatic stones Mori, Toshiyuki
2006
50-51 6 p. 1117-1137
21 p.
artikel
134 Medical and endoscopic therapy of primary sclerosing cholangitis Weismüller, Tobias J.
2011
50-51 6 p. 741-752
12 p.
artikel
135 Medical treatment of GORD. Emerging therapeutic targets and concepts Zerbib, Frank
2010
50-51 6 p. 937-946
10 p.
artikel
136 Medical treatment of portal hypertension Garcı́a-Pagán, Juan Carlos
2000
50-51 6 p. 895-909
15 p.
artikel
137 Methodological considerations for surveillance in GI practice Holme, Øyvind
2016
50-51 6 p. 867-878
12 p.
artikel
138 Microbiome measurement: Possibilities and pitfalls Radjabzadeh, Djawad
2017
50-51 6 p. 619-623
artikel
139 Microbiome, pattern recognition receptor function in health and inflammation Fawkner-Corbett, David
2017
50-51 6 p. 683-691
artikel
140 Microlithiasis and sludge Jüngst, Christoph
2006
50-51 6 p. 1053-1062
10 p.
artikel
141 Minimally invasive surgery for early lower GI cancer Bemelman, W.A.
2005
50-51 6 p. 993-1005
13 p.
artikel
142 Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studies Wang, Bruce C.M.
2013
50-51 6 p. 987-995
9 p.
artikel
143 Modern, new pharmacotherapy for obesity. A gastrointestinal approach Van Gaal, L.
2004
50-51 6 p. 1049-1072
24 p.
artikel
144 Mortality and economics in short bowel syndrome Schalamon, J
2003
50-51 6 p. 931-942
12 p.
artikel
145 Multimodal treatment of gastric cancer Moehler, Markus
2007
50-51 6 p. 965-981
17 p.
artikel
146 Multimodal treatment of oesophageal cancer Veuillez, Véronique
2007
50-51 6 p. 947-963
17 p.
artikel
147 Multimodal treatment of rectal cancer Glynne-Jones, Rob
2007
50-51 6 p. 1049-1070
22 p.
artikel
148 NAFLD, Helicobacter species and the intestinal microbiome Castaño-Rodríguez, Natalia
2017
50-51 6 p. 657-668
artikel
149 Natural history: The importance of viral load, liver damage and HCC Wursthorn, Karsten
2008
50-51 6 p. 1063-1079
17 p.
artikel
150 Neuroendocrine tumours of the small intestine Strosberg, Jonathan
2012
50-51 6 p. 755-773
19 p.
artikel
151 New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity Gupta, Rajnish A
2002
50-51 6 p. 945-956
12 p.
artikel
152 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course Cortez-Pinto, Helena
2004
50-51 6 p. 1089-1104
16 p.
artikel
153 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment Bugianesi, Elisabetta
2004
50-51 6 p. 1105-1116
12 p.
artikel
154 Non-invasive screening for colorectal cancer in Asia Chiu, Han-Mo
2015
50-51 6 p. 953-965
13 p.
artikel
155 Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success Chien, Rong-Nan
2008
50-51 6 p. 1081-1092
12 p.
artikel
156 Nutrition and oral health Budtz-Jørgensen, Ejvind
2001
50-51 6 p. 885-896
12 p.
artikel
157 Nutrition in the elderly Pirlich, Matthias
2001
50-51 6 p. 869-884
16 p.
artikel
158 Obesity: epidemiology and clinical aspects Formiguera, Xavier
2004
50-51 6 p. 1125-1146
22 p.
artikel
159 Obesity: surgical options Miller, Karl
2004
50-51 6 p. 1147-1165
19 p.
artikel
160 Oesophageal disorders: future developments Tam, William
2002
50-51 6 p. 811-833
23 p.
artikel
161 Organization of surveillance in GI practice Senore, Carlo
2016
50-51 6 p. 855-866
12 p.
artikel
162 Overview of gastrointestinal cancer prevention in Asia Park, Jong-Min
2015
50-51 6 p. 855-867
13 p.
artikel
163 Pancreatic cancer: From pathogenesis to cure Ducreux, Michel
2007
50-51 6 p. 997-1014
18 p.
artikel
164 Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances Ito, Tetsuhide
2012
50-51 6 p. 737-753
17 p.
artikel
165 Pathogenesis of autoimmune hepatitis Liberal, Rodrigo
2011
50-51 6 p. 653-664
12 p.
artikel
166 Pathogenesis of gallstones: a genetic perspective Grünhage, Frank
2006
50-51 6 p. 997-1015
19 p.
artikel
167 Pathogenesis of primary sclerosing cholangitis Pollheimer, Marion J.
2011
50-51 6 p. 727-739
13 p.
artikel
168 Pathology – Grading and staging of GEP-NETs Capelli, Paola
2012
50-51 6 p. 705-717
13 p.
artikel
169 Pathology of early lower GI cancer Geboes, Karel
2005
50-51 6 p. 963-978
16 p.
artikel
170 Pathology of early upper GI cancers Vieth, Michael
2005
50-51 6 p. 857-869
13 p.
artikel
171 Pathophysiology, diagnosis and treatment of ascites in cirrhosis Uriz, Juan
2000
50-51 6 p. 927-943
17 p.
artikel
172 Peginterferon and ribavirin in HCV: Improvement of sustained viral response Ferenci, P.
2008
50-51 6 p. 1109-1122
14 p.
artikel
173 Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues Buster, Erik H.C.J.
2008
50-51 6 p. 1093-1108
16 p.
artikel
174 Peptide receptor radionuclide therapy (PRRT) for GEP-NETs Bergsma, Hendrik
2012
50-51 6 p. 867-881
15 p.
artikel
175 Perception of gastro-oesophageal reflux Chua, Y.C.
2010
50-51 6 p. 883-891
9 p.
artikel
176 Perspectives and reflections on integrated digestive surgery Modlin, Irvin M.
2002
50-51 6 p. 885-914
30 p.
artikel
177 Pharmacological and alimentary alteration of the gastric barrier Boltin, Doron
2014
50-51 6 p. 981-994
14 p.
artikel
178 Physiology and organ-related pathology of the elderly: stomach ulcers Jones, J.I.W.
2001
50-51 6 p. 943-961
19 p.
artikel
179 Physiology and pathology of the oesophagus in the elderly patient Lock, Guntram
2001
50-51 6 p. 919-941
23 p.
artikel
180 Preface Pilotto, Alberto
2009
50-51 6 p. 791-792
2 p.
artikel
181 Preface Tytgat, G.N.J.
2002
50-51 6 p. vii-
1 p.
artikel
182 Preface Thomson, A.
2003
50-51 6 p. 877-
1 p.
artikel
183 Preface 2000
50-51 6 p. vii-
1 p.
artikel
184 Preface Thomson, A.B.R.
2001
50-51 6 p. vii-
1 p.
artikel
185 Preface Lau, James Y.W.
2015
50-51 6 p. 841-842
2 p.
artikel
186 Preface van Erpecum, Karel J.
2006
50-51 6 p. 979-980
2 p.
artikel
187 Preface Clandinin, Tom
2004
50-51 6 p. 1007-
1 p.
artikel
188 Preface Bergman, J.J.G.H.M.
2005
50-51 6 p. 831-832
2 p.
artikel
189 Preface Janssen, Harry
2008
50-51 6 p. 989-990
2 p.
artikel
190 Preface to “Gut microbiome in health and disease” Peppelenbosch, Maikel P.
2017
50-51 6 p. 605-606
artikel
191 Prevention of viral hepatitis (B and C) reassessed Van Herck, Koen
2008
50-51 6 p. 1009-1029
21 p.
artikel
192 Prevention strategies for esophageal cancer: Perspectives of the East vs. West Chung, Chen-Shuan
2015
50-51 6 p. 869-883
15 p.
artikel
193 Primary sclerosing cholangitis and malignancy Boberg, Kirsten Muri
2011
50-51 6 p. 753-764
12 p.
artikel
194 Psychological aspects of eating disorders Williamson, Donald A.
2004
50-51 6 p. 1073-1088
16 p.
artikel
195 Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours Sundin, Anders
2012
50-51 6 p. 803-818
16 p.
artikel
196 Review: Surveillance of patients with Barrett oesophagus Maes, Sielte
2016
50-51 6 p. 901-912
12 p.
artikel
197 Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment Freeman, Hugh J.
2004
50-51 6 p. 1167-1175
9 p.
artikel
198 Screening of gastric cancer in Asia Sugano, Kentaro
2015
50-51 6 p. 895-905
11 p.
artikel
199 Second look endoscopy in acute non-variceal upper gastrointestinal bleeding Chiu, Philip Wai Yan
2013
50-51 6 p. 905-911
7 p.
artikel
200 Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours Costa, F.P.
2012
50-51 6 p. 843-854
12 p.
artikel
201 Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs? Bruley des Varannes, Stanislas
2010
50-51 6 p. 905-921
17 p.
artikel
202 Small intestinal disorders in the elderly Thomson, Alan B.R.
2009
50-51 6 p. 861-874
14 p.
artikel
203 Splenomegaly, hypersplenism and coagulation abnormalities in liver disease McCormick, P.Aiden
2000
50-51 6 p. 1009-1031
23 p.
artikel
204 Surgery for GEP-NETs Knigge, Ulrich
2012
50-51 6 p. 819-831
13 p.
artikel
205 Surgical approaches and intestinal transplantation Benedetti, Enrico
2003
50-51 6 p. 1017-1040
24 p.
artikel
206 Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly di Sebastiano, Pierluigi
2009
50-51 6 p. 919-923
5 p.
artikel
207 Surgical aspects of symptomatic cholecystolithiasis and acute cholecystitis Keus, F.
2006
50-51 6 p. 1031-1051
21 p.
artikel
208 Surgical strategies for early esophageal adenocarcinoma Stein, H.J.
2005
50-51 6 p. 927-940
14 p.
artikel
209 Surgical therapy of gastro-oesophageal reflux disease Lundell, Lars
2010
50-51 6 p. 947-959
13 p.
artikel
210 Surgical treatment of portal hypertension Henderson, J.Michael
2000
50-51 6 p. 911-925
15 p.
artikel
211 Surveillance after colorectal polyp removal Jover, Rodrigo
2016
50-51 6 p. 937-948
12 p.
artikel
212 Surveillance after endoscopic and surgical resection of colorectal cancer Sekiguchi, Masau
2016
50-51 6 p. 959-970
12 p.
artikel
213 Surveillance for hepatocellular carcinoma Díaz-González, Álvaro
2016
50-51 6 p. 1001-1010
10 p.
artikel
214 Surveillance for neoplasia in the pancreas Overbeek, Kasper A.
2016
50-51 6 p. 971-986
16 p.
artikel
215 Surveillance in cholangiocellular carcinoma Wirth, Thomas C.
2016
50-51 6 p. 987-999
13 p.
artikel
216 Surveillance of patients at high-risk of squamous cell esophageal cancer Chaber-Ciopinska, A.
2016
50-51 6 p. 893-900
8 p.
artikel
217 Surveillance of patients with gastric precancerous conditions Lage, Jorge
2016
50-51 6 p. 913-922
10 p.
artikel
218 Surveillance of patients with hereditary gastrointestinal cancer syndromes Moreira, Leticia
2016
50-51 6 p. 923-935
13 p.
artikel
219 Surveillance of patients with inflammatory bowel disease Yu, Jessica X.
2016
50-51 6 p. 949-958
10 p.
artikel
220 Symptoms and diagnosis of gallbladder stones Portincasa, P.
2006
50-51 6 p. 1017-1029
13 p.
artikel
221 Symptoms, diagnosis and endoscopic management of common bile duct stones Caddy, Grant R.
2006
50-51 6 p. 1085-1101
17 p.
artikel
222 Taming the mucosal immune response in Crohn's disease van Deventer, S.J.H.
2002
50-51 6 p. 1035-1043
9 p.
artikel
223 Targeted screening for colorectal cancer in high-risk individuals Wong, Martin C.S.
2015
50-51 6 p. 941-951
11 p.
artikel
224 The benefit of animal models for autoimmune hepatitis Jaeckel, Elmar
2011
50-51 6 p. 643-651
9 p.
artikel
225 The changing epidemiology of Asian digestive cancers: From etiologies and incidences to preventive strategies Wu, Chun-Ying
2015
50-51 6 p. 843-853
11 p.
artikel
226 The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disorders Pilotto, Alberto
2009
50-51 6 p. 829-837
9 p.
artikel
227 The current future understanding of inflammatory bowel disease Podolsky, Daniel K.
2002
50-51 6 p. 933-943
11 p.
artikel
228 The diagnostic and therapeutic approach for primary solid liver tumours in adults Verslype, Chris
2007
50-51 6 p. 983-996
14 p.
artikel
229 The fight against gastric cancer – the IARC Working Group report Herrero, Rolando
2014
50-51 6 p. 1107-1114
8 p.
artikel
230 The gastrointestinal microbiome – Functional interference between stomach and intestine Lopetuso, Loris R.
2014
50-51 6 p. 995-1002
8 p.
artikel
231 The gastrointestinal microbiota and its role in oncogenesis Lam, S.Y.
2017
50-51 6 p. 607-618
artikel
232 The global challenge of a healthy stomach Bornschein, Jan
2014
50-51 6 p. 949-951
3 p.
artikel
233 The hepatopulmonary syndrome Aboussouan, Loutfi S
2000
50-51 6 p. 1033-1048
16 p.
artikel
234 The host–microbe interface within the gut Shanahan, Fergus
2002
50-51 6 p. 915-931
17 p.
artikel
235 The increasing need for health-economic assessment in gastrointestinal and liver diseases Bardou, Marc
2013
50-51 6 p. 829-830
2 p.
artikel
236 The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer Van Cutsem, Eric
2007
50-51 6 p. 1089-1108
20 p.
artikel
237 The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms Orlando, Roy C.
2010
50-51 6 p. 873-882
10 p.
artikel
238 The multidisciplinary management of gastrointestinal cancer Van Cutsem, Eric
2007
50-51 6 p. 919-920
2 p.
artikel
239 Therapy of autoimmune hepatitis Strassburg, Christian P.
2011
50-51 6 p. 673-687
15 p.
artikel
240 The refluxate: The impact of its magnitude, composition and distribution Woodland, Philip
2010
50-51 6 p. 861-871
11 p.
artikel
241 The relation between body mass and gastro-oesophageal reflux Nilsson, Magnus
2004
50-51 6 p. 1117-1123
7 p.
artikel
242 The role of delayed gastric emptying and impaired oesophageal body motility Penagini, Roberto
2010
50-51 6 p. 831-845
15 p.
artikel
243 The role of exercise for weight loss and maintenance Donnelly, Joseph E.
2004
50-51 6 p. 1009-1029
21 p.
artikel
244 The stomach–brain axis Holtmann, Gerald
2014
50-51 6 p. 967-979
13 p.
artikel
245 The use of molecular markers in the diagnosis and treatment of colorectal cancer Tejpar, Sabine
2007
50-51 6 p. 1071-1087
17 p.
artikel
246 Treatment of GERD complications (Barrett’s, peptic stricture) and extra-oesophageal syndromes Bansal, Ajay
2010
50-51 6 p. 961-968
8 p.
artikel
247 Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies Bardou, Marc
2013
50-51 6 p. 881-892
12 p.
artikel
248 Understanding and controlling hepatobiliary function Oude Elferink, Ronald P.J.
2002
50-51 6 p. 1025-1034
10 p.
artikel
249 Understanding and controlling the enteric nervous system Boeckxstaens, G.E.
2002
50-51 6 p. 1013-1023
11 p.
artikel
250 What is the impact of disease prevalence upon health technology assessment? Rotily, Michel
2013
50-51 6 p. 853-865
13 p.
artikel
                             250 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland